Salvage high dose rate brachytherapy (HDR-BT)

Topic Status Incomplete

Salvage high dose rate brachytherapy (HDR-BT) for localised relapse of prostate cancer after prior curative intent radiotherapy.

Summary

 

Health Technology Wales researchers searched for evidence on the clinical and cost-effectiveness of salvage HDR-BT for localised relapse of prostate cancer after prior primary treatment.

Based on the evidence identified, HTW’s Assessment Group concluded to progress this topic to Evidence Appraisal.

Topic Exploration Report

TER596 05.2025